Met Life Investment Management, LLC Satsuma Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$3.85 - $28.47 $17,575 - $129,965	-4,565 Closed	0 $0
Q2 2020 May 24, 2024	BUY	$16.01 - $34.69 $73,085 - $158,359	4,565 New	4,565 $131 Million
Q2 2020 Jun 26, 2023	BUY	$16.01 - $34.69 $73,085 - $158,359	4,565 New	4,565 $131,000
Q2 2020 Mar 22, 2023	BUY	$16.01 - $34.69 $73,085 - $158,359	4,565 New	4,565 $131,000
Q2 2020 Aug 14, 2020	BUY	$16.01 - $34.69 $73,085 - $158,359	4,565 New	4,565 $131,000

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.